{"title":"Preventive Cardiology","description":"","products":[{"product_id":"vascular-medicine-a-companion-to-braunwald-s-heart-disease","title":"Vascular Medicine: A Companion to Braunwald’s Heart Disease, 3rd Edition","description":"\u003cp\u003e\u003cstrong\u003eBy Mark Creager M.D. F.A.H.A F.A.C.C., Joshua A. Beckman MD, Joseph Loscalzo MD PhD\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003eWith authoritative coverage of everything from recent discoveries in the field of vascular biology to recent clinical trials and evidence-based treatment strategies, Vascular Medicine, 3rd Edition, is your go-to resource for improving your patients’ cardiovascular health. Part of the Braunwald family of renowned cardiology references, this updated volume integrates a contemporary understanding of vascular biology with a thorough review of clinical vascular diseases, making it an ideal reference for vascular medicine specialists, general cardiologists, interventional cardiologists, vascular surgeons, and interventional radiologists.\u003c\/p\u003e\n\u003cul class=\"a-unordered-list a-vertical\"\u003e\n\u003cli\u003eIncorporates technologic advances in vascular imaging – including ultrasound, MRI, CTA, and catheter-based angiography – along with more than 230 new figures, providing an up-to-date and complete view of the vascular system and vascular diseases.\u003c\/li\u003e\n\u003cli\u003eCovers novel antithrombotic therapies for peripheral artery disease and venous thromboemboism, advances in endovascular interventions for aortic aneurysms, and today’s best surgical treatments for vascular diseases.\u003c\/li\u003e\n\u003cli\u003eIncludes seven new chapters: Pathobiology of Aortic Aneurysms; Pathobiology and Assessment of Cardiovascular Fibrosis; Large Vessel Vasculitis; Medium and Small Vessel Vasculitis; Epidemiology and Prognosis of Venous Thromboembolic Disease; Fibromuscular Dysplasia; and Dermatologic Manifestations of Vascular Disease.\u003c\/li\u003e\n\u003cli\u003eDiscusses methods for aggressive patient management and disease prevention to ensure minimal risk of further cardiovascular problems.\u003c\/li\u003e\n\u003cli\u003eKeeps you current with ACC\/AHA and ECC guidelines and the best ways to implement them in clinical practice.\u003c\/li\u003e\n\u003cli\u003eEnhanced eBook version included with purchase, which allows you to access all of the text, figures, and references from the book on a variety of devices\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch3\u003eProduct Details\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003ePublisher ‏ : ‎ Elsevier\u003c\/li\u003e\n\u003cli\u003ePublication date ‏ : ‎ July 1, 2019\u003c\/li\u003e\n\u003cli\u003eEdition ‏ : ‎ 3rd\u003c\/li\u003e\n\u003cli\u003eLanguage ‏ : ‎ English\u003c\/li\u003e\n\u003cli\u003eISBN-10 ‏ : ‎ 0323636004\u003c\/li\u003e\n\u003cli\u003eISBN-13 ‏ : ‎ 978-0323636001\u003c\/li\u003e\n\u003cli\u003ePart of series ‏ : ‎ Companion to Braunwald's Heart Disease\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Docebook","offers":[{"title":"Default Title","offer_id":48033136869611,"sku":"0-00-AN","price":39.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0821\/3105\/8923\/files\/HospitalforSpecialSurgeryContemporaryTopicsinVasculitis2024-2026-04-03T230032.593.png?v=1775253099"},{"product_id":"clinical-lipidology-braunwald-heart-disease-2nd-edition-medical-textbook-pdf","title":"Clinical Lipidology: A Companion to Braunwald’s Heart Disease, 2nd Edition","description":"\u003cp\u003e\u003cstrong\u003eby Christie M. Ballantyne\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003e\u003ci\u003eClinical Lipidology\u003c\/i\u003e\u003c\/b\u003e, a companion to\u003cspan\u003e \u003c\/span\u003e\u003cb\u003e\u003ci\u003eBraunwald’s Heart Disease,\u003c\/i\u003e\u003c\/b\u003e\u003cspan\u003e \u003c\/span\u003eis designed to guide you through the ever-changing therapeutic management of patients with high cholesterol levels. From basic science to pathogenesis of atherothrombotic disease, to risk assessment and the latest therapy options, this medical reference book offers\u003cspan\u003e \u003c\/span\u003e\u003cb\u003eunparalleled coverage and expert guidance on lipidology\u003c\/b\u003e\u003cspan\u003e \u003c\/span\u003ein a straightforward, accessible, and user-friendly style.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003eGet authoritative guidance\u003c\/b\u003e\u003cspan\u003e \u003c\/span\u003efrom some of the foremost experts in the field.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eEasily access key content\u003c\/b\u003e\u003cspan\u003e \u003c\/span\u003ewith help from treatment algorithms.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003eAccess options and evidence-based solutions\u003c\/b\u003e\u003cspan\u003e \u003c\/span\u003efor every type of patient scenario, as well as the latest clinical guidelines and clinically relevant evidence on risk assessment, special patient populations, and therapy, including recently approved and experimental therapies.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eRemain at the forefront of the cardiology field\u003c\/b\u003e\u003cspan\u003e \u003c\/span\u003ewith up-to-date chapters on treatment guidelines; diet, exercise, and weight loss; pharmacologic therapies such as statins, omega-3 fatty acids, and combination therapy; evolving targets of therapy such as PCSK9 inhibition, CETP inhibition, and inflammation\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003ePrepare for special patient populations\u003c\/b\u003e\u003cspan\u003e \u003c\/span\u003esuch as children and adolescents; women and the elderly; transplant recipients; HIV patients; and those with chronic renal disease, familial hypercholesterolemia, other severe hypercholesterolemias, diabetes, or other metabolic syndromes.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eTake advantage of a format\u003c\/b\u003e\u003cspan\u003e \u003c\/span\u003ethat follows that of the well-known and internationally recognized\u003cspan\u003e \u003c\/span\u003e\u003cb\u003e\u003ci\u003eBraunwald’s Heart Disease.\u003c\/i\u003e\u003c\/b\u003e\n\u003c\/li\u003e\n\u003cli\u003e\u003cb\u003eExpert Consult eBook version included with purchase.\u003c\/b\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cbr\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003ctable width=\"100%\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eFormat\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003ePDF Digital Download\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eEdition\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e2nd Edition\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eAuthor\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eChristie M. Ballantyne\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eFile Size\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e72.0 MB\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eLanguage\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eEnglish\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePage Count\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e700 (estimated: true)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eSubject\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eCardiovascular Medicine\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eSeries\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eBraunwald's Heart Disease Companion\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e","brand":"Elsevier","offers":[{"title":"Default Title","offer_id":48033137098987,"sku":"AN-000-0","price":35.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0821\/3105\/8923\/files\/HospitalforSpecialSurgeryContemporaryTopicsinVasculitis2024_100.png?v=1775251752"},{"product_id":"opie-s-cardiovascular-drugs-9th-edition-companion-to-braunwald-s-heart-disease","title":"Opie’s Cardiovascular Drugs: A Companion to Braunwald’s Heart Disease, 9th Edition","description":"\u003cdiv id=\"bylineInfo\" class=\"a-section a-spacing-micro bylineHidden feature\"\u003eby\u003cspan class=\"author notFaded\" data-width=\"\"\u003e\u003cb\u003eDeepak L. Bhatt MD MPH\u003c\/b\u003e\u003cspan class=\"contribution\"\u003e\u003cspan class=\"a-color-secondary\"\u003e(Author)\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\n\u003c\/div\u003e\n\u003cdiv\u003eAuthoritative, portable, and up to date, Opie’s Cardiovascular Drugs, 9th Edition, is the definitive reference for quick access to frequently used drugs in all phases of care for cardiac patients. Now a part of the Braunwald family of renowned cardiology references, this compact title provides crucial information in an easily accessible format―ideal for cardiologists, residents, cardiology fellows, medical students, nurses, and other cardiac care providers. Updated to include the latest guidelines and evidence-based implications, it offers clear and concise explanations and pertinent clinical facts for all classes of cardiac drugs, as well as all the latest clinical trial results and evidence for the pharmacologic treatment of heart disease.\n\u003cp\u003e \u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eUses a new, consistent format for each drug class: overview and guidelines for use, mechanisms of action, differences among drugs in class, data for use, side effects, and drug interactions.\u003c\/li\u003e\n\u003cli\u003eCovers key topics such as new ESC and NLA guidelines, advances in lipid-lowering therapy, new diabetes drugs that improve cardiovascular outcomes, obesity drugs and cardiovascular and metabolic effects, drugs targeting inflammation, and combinations of antithrombotic therapies with analysis of risk-benefit.\u003c\/li\u003e\n\u003cli\u003eProvides guidance on how to effectively manage comorbid diseases.\u003c\/li\u003e\n\u003cli\u003eContains dozens of unique “Opiegram” diagrams that demystify complex mechanisms of action and other drug processes―many updated to reflect current pathologic understanding of mechanisms.\u003c\/li\u003e\n\u003cli\u003eEnhanced eBook version included with purchase, which allows you to access all of the text, figures, and references from the book on a variety of devices\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cp\u003e\u003cbr\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003ctable width=\"100%\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eFormat\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eDigital PDF Download\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eEdition\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e9th Edition\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eAuthor\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eDeepak L. Bhatt\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eFile Size\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e28.1 MB\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eLanguage\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eEnglish\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePublication Series\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eBraunwald’s Heart Disease Companion\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePrimary Topic\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eCardiovascular Pharmacology\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eContent Type\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eDrug Profiles and Clinical Scenarios\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e","brand":"Braunwald's Companion","offers":[{"title":"Default Title","offer_id":48033137131755,"sku":"PDF-00-0-0-AN","price":29.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0821\/3105\/8923\/files\/HospitalforSpecialSurgeryContemporaryTopicsinVasculitis2024_99.png?v=1775251556"},{"product_id":"the-net-heart-book-infectious-disease-and-cardiology-medical-pdf","title":"The NET-Heart Book: Neglected Tropical Diseases and other Infectious Diseases affecting the Heart","description":"\u003cp\u003eBy Clara Saldarriaga, Adrian Baranchuk\u003c\/p\u003e\n\u003cdiv\u003e\n\u003ci\u003eNeglected Tropical Diseases and other Infectious Diseases Affecting the Heart\u003c\/i\u003e\u003cspan\u003e \u003c\/span\u003eprovides a comprehensive and systematic review on the literature surrounding Neglected Tropical Diseases and infectious diseases and how they affect the heart. Written by Emerging Leaders of the Interamerican Society of Cardiology (SIAC), the book includes the latest research findings, covering the cardiac involvement of a range of viral, bacterial and parasitic diseases, including COVID19, HIV, Zika, Lyme Disease, and more. Chapters cover epidemiology, the physiopathology of cardiovascular involvement, symptoms, diagnosis, and treatment options for each disease, making the book suitable to researchers, scientists, clinicians and physicians in the field.\u003c\/div\u003e\n\u003ch3\u003eProduct Details\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003ePublisher ‏ : ‎ Academic Press; 1st edition (November 5, 2021)\u003c\/li\u003e\n\u003cli\u003eLanguage ‏ : ‎ English\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eISBN-10 ‏ : ‎ 0323911226\u003c\/li\u003e\n\u003cli\u003eISBN-13 ‏ : ‎ 978-0323911221\u003c\/li\u003e\n\u003cli\u003eISBN-13 ‏ : ‎ 9780323911221\u003c\/li\u003e\n\u003cli\u003eeText ISBN: 9780323911238\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cbr\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003ctable width=\"100%\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eFormat\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003ePDF Digital Download\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eFile Size\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e5.7 MB\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eAuthors\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eClara Saldarriaga, Adrian Baranchuk\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eLanguage\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eEnglish\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePage Count\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e450 (estimated: true)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eSubject\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eCardiology and Infectious Diseases\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eClinical Focus\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eEpidemiology, Physiopathology, Diagnosis, and Treatment\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCovered Diseases\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eCOVID-19, HIV, Zika, Lyme Disease, Parasitic Diseases\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e","brand":"Interamerican Society of Cardiology (SIAC)","offers":[{"title":"Default Title","offer_id":48033137656043,"sku":"AB-9-","price":39.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0821\/3105\/8923\/files\/HospitalforSpecialSurgeryContemporaryTopicsinVasculitis2024_86.png?v=1775243181"},{"product_id":"hearts-in-the-americas-comprehensive-guide-for-cardiovascular-implementation","title":"HEARTS in the Americas: Guide and Essentials for Implementation","description":"\u003cp\u003eBy Pan American Health Organization\u003cbr\u003eThe World Health Organization (WHO) launched the Global Hearts Initiative and its HEARTS Technical Package in 2016. Its aim is to improve clinical preventive services in primary health care (PHC) using highly effective, scalable, sustainable, and proven interventions. As the WHO Regional Office for the Americas, the Pan American Health Organization (PAHO) is developing and coordinating the HEARTS in the Americas Initiative with a clear vision: By 2025, HEARTS will be the institutionalized model for cardiovascular disease risk management, including hypertension, diabetes, and dyslipidemia in primary health care in the Americas.The HEARTS in the Americas Initiative is entering its sixth year of implementation, having expanded from the original cohort of 4 countries to 22 current countries implementing the HEARTS model. The accumulation of knowledge, practices, and experiences from the field and from different levels of implementation has been compiled in this new Guide and Essentials for Implementation. This manual complements the WHO HEARTS technical package Implementation Guide. Expanding on specific lessons learned from the systematic implementation of HEARTS in the Americas as it spans various roles and requires coordination across ministry of health (MOH) departments, stakeholders, partner agencies, scientific societies, and academic institutions. Documenting the implementation and scale-up experiences of countries in the Americas is timely to propel forward the institutionalization of the HEARTS model for cardiovascular disease (CVD) risk management, including hypertension, diabetes, and dyslipidemia in PHC in the Americas by 2025. This manual is designed to be practical and user-friendly. It aims to guide implementers at national and subnational levels to navigate throughout different stages of implementation and to ensure longtime sustainability. The manual is written for national focal points, managers and coordinators at subregional, provincial, district, municipal level, and health facilities implementing HEARTS. It is intended to answer frequently asked questions about the premises, objectives, components, and steps for implementation of the HEARTS in the Americas Initiative.\u003ci class=\"a-icon a-icon-extender-expand\"\u003e\u003c\/i\u003e\u003c\/p\u003e\n\u003ch3\u003eProduct Details\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003ePublisher ‏ : ‎ Pan American Health Organization (March 4, 2022)\u003c\/li\u003e\n\u003cli\u003eLanguage ‏ : ‎ English\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eISBN-10 ‏ : ‎ 9275125295\u003c\/li\u003e\n\u003cli\u003eISBN-13 ‏ : ‎ 978-9275125298\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cbr\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003ctable width=\"100%\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCreator\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003ePan American Health Organization (PAHO)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eFile Format\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eDigital PDF (Estimated)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eFile Size\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e1.3 MB\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eLanguage\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eEnglish\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eClinical Focus\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eCardiovascular Disease Risk Management\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePrimary Applications\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eHypertension, Diabetes, and Dyslipidemia\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eImplementation Scale\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eNational and Subnational\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e","brand":"Pan American Health Organization","offers":[{"title":"Default Title","offer_id":48033137688811,"sku":"AB-2","price":27.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0821\/3105\/8923\/files\/HospitalforSpecialSurgeryContemporaryTopicsinVasculitis2024_84.png?v=1775242740"},{"product_id":"spc-manual-of-preventive-cardiology-contemporary-cardiology-2nd-edition-2021-edition","title":"ASPC Manual of Preventive Cardiology (Contemporary Cardiology) 2nd edition (2021 Edition)","description":"\u003cp\u003eBy: Nathan D. Wong, Ezra A. Amsterdam, Peter P. Toth (eds.)\u003c\/p\u003e\n\u003cp\u003ePDF: 17.9MB\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eThis second edition\u003c\/strong\u003e provides an updated review of the current guidelines and practice standards for the clinical management of cardiovascular risk factors and prevention of cardiovascular diseases. Endorsed by the American Society for Preventive Cardiology, this practical textbook includes concise descriptions of major and newer risk factors, biomarkers, and best practices in managing and preventing cardiovascular disease. The manual contains chapters on the epidemiology and risk factors for a variety of cardiovascular diseases including dyslipidemia, hypertension, diabetes, inflammation, and ischemic stroke. It examines behavioral factors, psychosocial stress, family history, nutrition, physical activity, smoking, alcohol use, and other sociocultural factors. In addition, the book discusses new imaging strategies in the detection of cardiovascular disease, prevention of heart failure, atrial fibrillation, and peripheral arterial disease, and prevention for special populations. The manual’s recommendations are based on guidelines endorsed by the American College of Cardiology, the American Heart Association, and other major societies.\u003cbr\u003eThe second edition of the \u003cspan class=\"a-text-italic\"\u003eASPC Manual of Preventive Cardiology\u003c\/span\u003e is an essential resource for physicians, medical students, residents, fellows, nurses, and other healthcare professionals and researchers in cardiology, primary care, health promotion and disease prevention, exercise physiology, and pharmacotherapy.\u003c\/p\u003e\n\u003ctable width=\"100%\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eFormat\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eDigital PDF\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eFile Size\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e17.9 MB\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eEdition\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e2nd Edition\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePublication Year\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e2021\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eSeries\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eContemporary Cardiology\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eEditors\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eNathan D. Wong, Ezra A. Amsterdam, Peter P. Toth\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eLanguage\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eEnglish\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eEndorsement\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eAmerican Society for Preventive Cardiology (ASPC)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e","brand":"Docebook","offers":[{"title":"Default Title","offer_id":48033146863851,"sku":"Z-0","price":19.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0821\/3105\/8923\/files\/Untitleddesign-2026-04-01T161733.636.png?v=1775056133"},{"product_id":"providence-regional-medical-center-everett-heart-stroke-essentials-for-primary-care-2025","title":"Providence Regional Medical Center Everett Heart \u0026 Stroke Essentials for Primary Care 2025","description":"\u003cp\u003e\u003cstrong\u003e+ Include: 10 videos + 1 pdf, size: 5.27 GB\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e+ Target Audience: primary care physicians in emergency medicine, critical care, cardiac, telemetry and neurology specialties\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e+ Information:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eHeart \u0026amp; Stroke Essentials for Primary Care 2025 June 20, 2025\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eWOULD YOU LIKE TO KNOW about the most recent innovations in technology and prevention in Cardio \u0026amp; Cerebrovascular Disease? Conference Chairs Dr. Apurva Badheka and Dr. Tarvinder Singh, Planners and the Medical Education Department at Providence Regional Medical Center Everett would like to invite you to the: Heart \u0026amp; Stroke Essentials for Primary Care\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCOURSE DESCRIPTION:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eJoin us for a full day of presentations on Friday, June 20, 2025, dealing with the most current issues and topics in providing treatment to patients with cardiac \u0026amp; stroke issues in the Primary Care setting. Presentations by regionally and nationally recognized speakers will include topics on the latest and most advanced technologies in prevention and treatment of cardiac and cerebrovascular issues. The Heart \u0026amp; Stroke Essentials for Primary Care Conference is designed to enhance the knowledge and competence of healthcare professionals who treat patients with cardiac and stroke disease and dysfunction. Current  scientific research, bestpractices, diagnostic and therapeutic approaches in several areas of cardiac and stroke medicine and prevention will be presented.\u003c\/p\u003e\n\u003ch3\u003e Who Should Attend\u003c\/h3\u003e\n\u003cp\u003eThis meeting is ideal for primary care physicians and nurses specializing in emergency medicine, critical care, cardiac, telemetry and neurology specialties but also anyone whose practice might include patients who are at risk for, or who have experienced heart and stroke episodes or events. Celebrating multiple years of Joint Commission Stroke Center Certification and our Thrombectomy-Capable Stroke Center Certification, this Providence Everett conference will feature the latest updates in Heart \u0026amp; Stroke essentials.\u003c\/p\u003e\n\u003cp\u003eThe following medical specialties are encouraged to attend: Internal Medicine, Primary Care, Hospitalists, Family Practice and Preventive Medicine.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003ePrimary care physicians (family medicine, internal medicine, general practice) managing cardiovascular risk factors and stroke prevention.\u003c\/li\u003e\n\u003cli\u003eNurse practitioners and physician assistants working in outpatient clinics or urgent care.\u003c\/li\u003e\n\u003cli\u003eHospitalists and internists who co‑manage patients with heart disease or stroke risk.\u003c\/li\u003e\n\u003cli\u003eCardiology and neurology clinicians seeking a refresher on primary care–focused strategies.\u003c\/li\u003e\n\u003cli\u003eResidents and fellows preparing for board exams or transitioning into practice.\u003c\/li\u003e\n\u003cli\u003ePharmacists and nurses involved in patient education and medication management.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e What You’ll Learn\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eCardiovascular risk assessment and prevention: hypertension, hyperlipidemia, diabetes, obesity, and lifestyle interventions.\u003c\/li\u003e\n\u003cli\u003eStroke essentials for primary care: recognition of early signs, secondary prevention, and referral pathways.\u003c\/li\u003e\n\u003cli\u003eUpdates in pharmacologic therapy: statins, antihypertensives, antiplatelets, anticoagulants, and new agents.\u003c\/li\u003e\n\u003cli\u003eGuideline updates: latest recommendations from AHA\/ACC and stroke societies.\u003c\/li\u003e\n\u003cli\u003eCase‑based discussions: practical approaches to managing patients with multiple comorbidities.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003e+ Topics:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e01 Cardiogenic Shock- Shifting the Onus to the Accepting Center for Advanced Critical Care.mp4\u003c\/li\u003e\n\u003cli\u003e02 Current Guidelines for Aortic Aneurysm.mp4\u003c\/li\u003e\n\u003cli\u003e03 Code STEMI- A Race Against Time.mp4\u003c\/li\u003e\n\u003cli\u003e04 Pulmonary Embolism and Interventions.mp4\u003c\/li\u003e\n\u003cli\u003e05 Intracranial Hemorrhage- Hypertension \u0026amp; Aneurysms.mp4\u003c\/li\u003e\n\u003cli\u003e06 Preventing Recurrent Stroke- Tailored Strategies, Emerging Therapies, \u0026amp; AI Innovations.mp4\u003c\/li\u003e\n\u003cli\u003e07 Stroke Code in Action- Optimizing Acute Stroke Management Code.mp4\u003c\/li\u003e\n\u003cli\u003e08 Update From International Stroke Convention 2025.mp4\u003c\/li\u003e\n\u003cli\u003e09 Reducing Uncertainty- The PET CT Advantage.mp4\u003c\/li\u003e\n\u003cli\u003e10 From Anatomy to Action- A Collaborative Approach to Vestibular Assessment \u0026amp; Treatment.mp4\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Docebook","offers":[{"title":"Default Title","offer_id":48033146929387,"sku":"MA-MS-40","price":79.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0821\/3105\/8923\/files\/Untitleddesign-2026-04-01T025819.502.png?v=1775008191"},{"product_id":"diabeto-cardiology-a-companion-to-braunwald-s-heart-disease-2nd-edition-pdf","title":"Diabeto-Cardiology: A Companion to Braunwald’s Heart Disease, 2nd edition ( PDF )","description":"\u003cp\u003eBy Darren K. McGuire MD PLLC, Nikolaus Marx MD FESC FAHA\u003c\/p\u003e\n\u003cp\u003ePart of the renowned Braunwald family of references, Diabeto-Cardiology, 2nd Edition, provides today’s clinicians with clear, authoritative guidance on the complex challenges of providing care to patients with cardiovascular and diabetes co-morbidities. Drs. Darren K. McGuire and Nikolaus Marx, along with a leading team of experts in cardiology and diabetes, address boththe foundational aspects and clinical implications for this growing number of patients, including recent breakthrough therapies and new medications that have contributed to newer and more effective treatments and improved patient outcomes. From cover to cover, this second edition offers reliable and current point-of-care coverage of the interwoven care needs of patients with these complex co-morbidities, making it an ideal resource for practitioners at all levels of experience.\u003c\/p\u003e\n\u003cul class=\"a-unordered-list a-vertical\"\u003e\n\u003cli\u003eDiscusses cutting-edge therapeutic approaches to the medical care of cardiology patients with diabetes, combining coverage of the latest understanding of the complex relationship between diabetes and cardiovascular disease with recent clinical advances.\u003c\/li\u003e\n\u003cli\u003eOffers a contemporary, clinical focus based on a new understanding of underlying pathologies, as well as application of evidence from clinical trials that have dramatically changed treatment and affected both cardiology and endocrinology practice.\u003c\/li\u003e\n\u003cli\u003eIncludes state-of-the-art coverage of antihyperglycemic medications that have demonstrated efficacy to reduce risk for atherosclerotic cardiovascular disease, heart failure, and kidney disease progression, that have affected a revolution of therapy in both cardiology and endocrinology.\u003c\/li\u003e\n\u003cli\u003eFeatures a practical, concise presentation with a focus on actionable clinical content, including new Clinical Practice Points and Take Home Summaries.\u003c\/li\u003e\n\u003cli\u003eAn eBook version is included with purchase. The eBook allows you to access all of the text, figures and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud. Additional digital ancillary content may publish up to 6 weeks following the publication date.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eProduct Details\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003ePublisher ‏ : ‎ Saunders\u003c\/li\u003e\n\u003cli\u003ePublication date ‏ : ‎ March 3, 2026\u003c\/li\u003e\n\u003cli\u003eEdition ‏ : ‎ 2nd\u003c\/li\u003e\n\u003cli\u003eLanguage ‏ : ‎ English\u003c\/li\u003e\n\u003cli\u003eISBN-10 ‏ : ‎ 0323878628\u003c\/li\u003e\n\u003cli\u003eISBN-13 ‏ : ‎ 978-0323878623\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch2 class=\"tab-heading\"\u003eSpecification\u003c\/h2\u003e\n\u003cdiv class=\"akf-det-table\"\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003cth\u003ePublished Year\u003c\/th\u003e\n\u003ctd\u003e2026\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eLanguage\u003c\/th\u003e\n\u003ctd\u003e‎English\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003ePublisher\u003c\/th\u003e\n\u003ctd\u003eElsevier\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eEdition :\u003c\/th\u003e\n\u003ctd\u003e2\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eFormat :\u003c\/th\u003e\n\u003ctd\u003ePublisher PDF\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eFile Size :\u003c\/th\u003e\n\u003ctd\u003e24.2\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eISBN :\u003c\/th\u003e\n\u003ctd\u003e978-0323878623\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e","brand":"Elsevier","offers":[{"title":"Default Title","offer_id":48046429536491,"sku":"AB-40","price":69.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0821\/3105\/8923\/files\/HospitalforSpecialSurgeryContemporaryTopicsinVasculitis2024-2026-04-04T175116.825.png?v=1775321004"},{"product_id":"tresch-and-aronow-s-cardiovascular-disease-in-older-adults-7th-edition-pdf","title":"Tresch and Aronow’s Cardiovascular Disease in Older Adults, 7th Edition (PDF)","description":"\u003cp\u003e\u003cstrong\u003eby Wilbert S. Aronow (ed.), Jerome L. Fleg (ed.), Michael W. Rich (ed.)\u003c\/strong\u003e\u003c\/p\u003e\n\u003cdiv\u003e\n\u003cdiv\u003e\n\u003cp\u003e\u003cspan\u003eThe Seventh Edition of \u003c\/span\u003e\u003cspan\u003eTresch and Aronow's Cardiovascular Disease in Older Adults\u003c\/span\u003e\u003cspan\u003e thoroughly updates the material in the sixth edition by renowned experts in geriatric cardiology. New features include a short list of Key Points at the start of each chapter to help guide the reader, a new chapter on Cardio-oncology in Older Adults, a topic of increasing importance, and new sections on geroscience, lifestyle factors in cardiovascular disease prevention, and cardiac amyloidosis added to existing chapters. These new features will enhance the value and relevance of this book as the definitive text in this growing field.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eKey Features:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003eProvides a comprehensive and accessible overview of the epidemiology, pathophysiology and treatment of cardiovascular disorders in older patients.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eUseful for adult cardiologists, primary care providers, geriatricians, cardiac nurses, nurse practitioners, and physician assistants, cardiac rehabilitation teams, physical and occupational therapists, and other practitioners working with older patients.\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch2 class=\"tab-heading\"\u003eSpecification\u003c\/h2\u003e\n\u003cdiv class=\"akf-det-table\"\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003cth\u003ePublished Year\u003c\/th\u003e\n\u003ctd\u003e2026\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eLanguage\u003c\/th\u003e\n\u003ctd\u003e‎English\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003ePublisher\u003c\/th\u003e\n\u003ctd\u003eCRC Press\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eEdition :\u003c\/th\u003e\n\u003ctd\u003e7\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eFormat :\u003c\/th\u003e\n\u003ctd\u003ePublisher PDF\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eFile Size :\u003c\/th\u003e\n\u003ctd\u003e49.9\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eISBN :\u003c\/th\u003e\n\u003ctd\u003e9781032940953, 9781040818145, 9781003568933, 9781040818046\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"CRC Press","offers":[{"title":"Default Title","offer_id":48046459125995,"sku":"AB-10","price":39.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0821\/3105\/8923\/files\/HospitalforSpecialSurgeryContemporaryTopicsinVasculitis2024-2026-04-04T180425.573.png?v=1775321759"},{"product_id":"cardiovascular-kidney-metabolic-syndrome-edition-1-original-pdf-from-publisher","title":"Cardiovascular-Kidney-Metabolic Syndrome Edition 1  (Original PDF from Publisher)","description":"\u003cp\u003e\u003cstrong\u003eby Mariana Floria (ed.), Daniela Maria Tanase (ed.)\u003c\/strong\u003e\u003c\/p\u003e\n\u003cdiv\u003e\n\u003cdiv\u003e\n\u003cp\u003e\u003cspan\u003eThis book presents the options available for the management of metabolic syndrome from the perspective of cardiac and renal medicine. Cardiovascular-kidney-metabolic (CKM) syndrome represents a complex interplay between cardiovascular diseases, metabolic conditions such as obesity and diabetes, and renal dysfunction. This multifaceted syndrome has gained significant attention in recent years due to its rising prevalence and profound implications for public health. Excessive body weight and insulin resistance contribute to increased cardiovascular risk and kidney dysfunction, creating a vicious cycle that exacerbates overall health outcomes. Understanding the pathophysiological mechanisms underlying CKM syndrome is essential for effective management. Key factors include chronic inflammation, oxidative stress and the dysregulation of hormones and metabolic pathways that not only affect cardiovascular health but also impair renal function. CKM syndrome can be conceptualized in various stages, each characterized by different severity and manifestations of the underlying conditions.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e\u003cbr\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eCardiovascular-Kidney-Metabolic Syndrome\u003c\/span\u003e\u003cspan\u003e provides a thorough review of the topic and presents a coherent strategy to manage the syndrome. With early identification crucial for timely intervention and to mitigate the progression of disease, this book discusses the use of routine assessments of cardiovascular health, renal function and metabolic parameters to facilitate early intervention and reduce the risk of severe complications.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e\u003cbr\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eTo address the complex interactions within CKM syndrome, a multidisciplinary approach is therefore imperative. This book represents a key resource for the different specialties involved —cardiology, nephrology and endocrinology — ensuring that patients receive comprehensive care that addresses all facets of their condition.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch2 class=\"tab-heading\"\u003eSpecification\u003c\/h2\u003e\n\u003cdiv class=\"akf-det-table\"\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003cth\u003ePublished Year\u003c\/th\u003e\n\u003ctd\u003e2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eLanguage\u003c\/th\u003e\n\u003ctd\u003e‎English\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003ePublisher\u003c\/th\u003e\n\u003ctd\u003eSpringer\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eEdition :\u003c\/th\u003e\n\u003ctd\u003e1\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eFormat :\u003c\/th\u003e\n\u003ctd\u003ePublisher PDF\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eFile Size :\u003c\/th\u003e\n\u003ctd\u003e11.2\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eISBN :\u003c\/th\u003e\n\u003ctd\u003e9783032114440, 9783032114457\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Springer","offers":[{"title":"Default Title","offer_id":48046516863211,"sku":"AB7","price":39.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0821\/3105\/8923\/files\/HospitalforSpecialSurgeryContemporaryTopicsinVasculitis2024-2026-04-04T190456.293.png?v=1775325369"},{"product_id":"complementary-and-alternative-cardiovascular-medicine-2004th-edition","title":"Complementary and Alternative Cardiovascular Medicine 2004th Edition","description":"\u003cp\u003e\u003cspan\u003eAcademic clinicians, clinical scientists, well-known practitioners of alternative medicine, and authors of popular works on the subject summarize the facts about complementary cardiovascular medicines so that physicians can confidently and knowledgeably advise their patients. The authors comprehensively explain the background for each important alternative therapy, its rationale, the evidence supporting its use, its possible interaction with standard medicines, and, where possible, what is known about its safety and efficacy. The therapies for treating coronary heart disease (CHD) range from the more commonly encountered herbs, vitamins, supplements, and dietary fats and oils, to such less familiar techniques as acupuncture, homeopathy, massage, chelation therapy, meditation, aroma therapies, prayer, and energy therapies.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003chr aria-hidden=\"true\" class=\"a-divider-normal bucketDivider\"\u003e\n\u003ch2\u003eProduct details\u003c\/h2\u003e\n\u003cdiv id=\"detailBullets_feature_div\"\u003e\n\u003cul class=\"a-unordered-list a-nostyle a-vertical a-spacing-none detail-bullet-list\"\u003e\n\u003cli\u003e\u003cspan class=\"a-list-item\"\u003e\u003cspan class=\"a-text-bold\"\u003ePublisher ‏ : ‎\u003cspan\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cspan\u003eHumana\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan class=\"a-list-item\"\u003e\u003cspan class=\"a-text-bold\"\u003ePublication date ‏ : ‎\u003cspan\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cspan\u003eMarch 5, 2004\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan class=\"a-list-item\"\u003e\u003cspan class=\"a-text-bold\"\u003eEdition ‏ : ‎\u003cspan\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cspan\u003e2004th\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan class=\"a-list-item\"\u003e\u003cspan class=\"a-text-bold\"\u003eLanguage ‏ : ‎\u003cspan\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cspan\u003eEnglish\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan class=\"a-list-item\"\u003e\u003cspan class=\"a-text-bold\"\u003ePrint length ‏ : ‎\u003cspan\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cspan\u003e296 pages\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan class=\"a-list-item\"\u003e\u003cspan class=\"a-text-bold\"\u003eISBN-10 ‏ : ‎\u003cspan\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cspan\u003e1588291863\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan class=\"a-list-item\"\u003e\u003cspan class=\"a-text-bold\"\u003eISBN-13 ‏ : ‎\u003cspan\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cspan\u003e978-1588291868\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e","brand":"Humana","offers":[{"title":"Default Title","offer_id":48046735982827,"sku":"AN0","price":25.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0821\/3105\/8923\/files\/HospitalforSpecialSurgeryContemporaryTopicsinVasculitis2024-2026-04-04T232859.511.png?v=1775341248"},{"product_id":"high-density-lipoproteins-dyslipidemia-and-coronary-heart-disease-edition-2010th","title":"High Density Lipoproteins, Dyslipidemia, and Coronary Heart Disease ‏ Edition 2010th","description":"\u003cp\u003e\u003cspan\u003eThis innovative book focuses on HDL and its relationships to triglyceride-rich particles. As-new therapies for HDL raising become available, a comprehensive understanding the role of HDL in Coronary Heart Disease is of great importance. This book is an excellent resource for educating physicians and scientists about dyslipidemia and HDL metabolism, including many exogenous substances which interact with and influence HDL. Readers will benefit from the unique visual exposition and the insights of international experts.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003chr aria-hidden=\"true\" class=\"a-divider-normal bucketDivider\"\u003e\n\u003ch2\u003eProduct details\u003c\/h2\u003e\n\u003cdiv id=\"detailBullets_feature_div\"\u003e\n\u003cul class=\"a-unordered-list a-nostyle a-vertical a-spacing-none detail-bullet-list\"\u003e\n\u003cli\u003e\u003cspan class=\"a-list-item\"\u003e\u003cspan class=\"a-text-bold\"\u003ePublisher ‏ : ‎\u003cspan\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cspan\u003eSpringer\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan class=\"a-list-item\"\u003e\u003cspan class=\"a-text-bold\"\u003ePublication date ‏ : ‎\u003cspan\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cspan\u003eMarch 15, 2010\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan class=\"a-list-item\"\u003e\u003cspan class=\"a-text-bold\"\u003eEdition ‏ : ‎\u003cspan\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cspan\u003e2010th\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan class=\"a-list-item\"\u003e\u003cspan class=\"a-text-bold\"\u003eLanguage ‏ : ‎\u003cspan\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cspan\u003eEnglish\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan class=\"a-list-item\"\u003e\u003cspan class=\"a-text-bold\"\u003ePrint length ‏ : ‎\u003cspan\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cspan\u003e216 pages\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan class=\"a-list-item\"\u003e\u003cspan class=\"a-text-bold\"\u003eISBN-10 ‏ : ‎\u003cspan\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cspan\u003e1441910581\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan class=\"a-list-item\"\u003e\u003cspan class=\"a-text-bold\"\u003eISBN-13 ‏ : ‎\u003cspan\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cspan\u003e978-1441910585\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e","brand":"Springer","offers":[{"title":"Default Title","offer_id":48046767407339,"sku":"AN0","price":29.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0821\/3105\/8923\/files\/HospitalforSpecialSurgeryContemporaryTopicsinVasculitis2024-2026-04-04T233158.223.png?v=1775341423"},{"product_id":"molecular-defects-in-cardiovascular-disease-2011th-edition","title":"Molecular Defects in Cardiovascular Disease 2011th Edition","description":"\u003cp\u003e\u003cspan\u003eMolecular Defects in Cardiovascular Disease provides an in-depth discussion of the molecular mechanisms underlying the genesis of cardiovascular defects and the implications this has on current and emerging targeted therapeutics.  Divided into three sections, this book covers the scientific foundations of our present understanding as well as the array of clinical manifestations and their treatment.  The first section covers Molecular Mechanisms of Heart Disease, with discussion of the development of cardiovascular dysfunction.  The remaining two sections provide a more clinical focus.  The second, Cardiac Hypertrophy and Heart Failure deals with metabolic derangements, Ca\u003c\/span\u003e\u003cspan\u003e\u003csup\u003e2+\u003c\/sup\u003e\u003c\/span\u003e\u003cspan\u003e handling, and subcellular remodeling.  It illustrates the wide variety of molecular defects which may serve as targets associated with the transition from cardiac hypertrophy to advanced heart failure.  The third section, Hypertension and Diabetes, provides molecular rationale for the pathogenesis of hypertension and diabetic cardiomyopathy, as well as highlighting the importance of hormones toward this end. \u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eA necessary resource for clinicians and researchers, this book elucidates the experimental basis of the practice of cardiology.  It is the culmination of our advances in the understanding of cardiovascular molecular biology and a blueprint for the efficacious use of targeted therapies.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003chr aria-hidden=\"true\" class=\"a-divider-normal bucketDivider\"\u003e\n\u003ch2\u003eProduct details\u003c\/h2\u003e\n\u003cdiv id=\"detailBullets_feature_div\"\u003e\n\u003cul class=\"a-unordered-list a-nostyle a-vertical a-spacing-none detail-bullet-list\"\u003e\n\u003cli\u003e\u003cspan class=\"a-list-item\"\u003e\u003cspan class=\"a-text-bold\"\u003ePublisher ‏ : ‎\u003cspan\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cspan\u003eSpringer\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan class=\"a-list-item\"\u003e\u003cspan class=\"a-text-bold\"\u003ePublication date ‏ : ‎\u003cspan\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cspan\u003eAugust 9, 2011\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan class=\"a-list-item\"\u003e\u003cspan class=\"a-text-bold\"\u003eEdition ‏ : ‎\u003cspan\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cspan\u003e2011th\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan class=\"a-list-item\"\u003e\u003cspan class=\"a-text-bold\"\u003eLanguage ‏ : ‎\u003cspan\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cspan\u003eEnglish\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan class=\"a-list-item\"\u003e\u003cspan class=\"a-text-bold\"\u003ePrint length ‏ : ‎\u003cspan\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cspan\u003e400 pages\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan class=\"a-list-item\"\u003e\u003cspan class=\"a-text-bold\"\u003eISBN-10 ‏ : ‎\u003cspan\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cspan\u003e1441971297\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan class=\"a-list-item\"\u003e\u003cspan class=\"a-text-bold\"\u003eISBN-13 ‏ : ‎\u003cspan\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cspan\u003e978-1441971296\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e","brand":"Springer","offers":[{"title":"Default Title","offer_id":48046855586027,"sku":"AN0","price":29.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0821\/3105\/8923\/files\/HospitalforSpecialSurgeryContemporaryTopicsinVasculitis2024-2026-04-05T003047.587.png?v=1775344907"},{"product_id":"heart-in-diabetes-9th-annual-heart-in-diabetes-conference-2025","title":"Heart in Diabetes 9th Annual Heart in Diabetes Conference 2025","description":"\u003ch1 class=\"product_title entry-title\"\u003eHeart in Diabetes 9th Annual Heart in Diabetes Conference 2025\u003c\/h1\u003e\n\u003cp\u003e\u003cstrong\u003e+ Include: 72 Videos (.mp4) + 72 Audios (.mp3) + 72 Subtitles (.vtt) + 57 PDFs, size: 32.09 GB\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e+ Target Audience: cardiologists, endocrinologists, and nephrologists\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e+ Information:\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch2 data-path-to-node=\"0\"\u003e1. Overview\u003c\/h2\u003e\n\u003cp data-path-to-node=\"1\"\u003eThe Heart in Diabetes 9th Annual Conference 2025 provides a comprehensive clinical exploration of the intersection between cardiovascular, renal, and metabolic diseases. The program delivers expert insights into managing resistant hypertension, chronic kidney disease, heart failure, obesity, and dyslipidemia, emphasizing the latest pharmacological advancements such as GLP-1 receptor agonists, SGLT2 inhibitors, and novel lipid-lowering therapies.\u003c\/p\u003e\n\u003cp data-path-to-node=\"1\"\u003e\u003cb data-path-to-node=\"1\" data-index-in-node=\"450\"\u003eCourse Date:\u003c\/b\u003e 2025\u003c\/p\u003e\n\u003ch2 data-path-to-node=\"2\"\u003e2. Learning Objectives\u003c\/h2\u003e\n\u003cul data-path-to-node=\"3\"\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"3,0,0\"\u003eEvaluate the pathophysiology and clinical management of cardiorenal metabolic diseases, including resistant hypertension and diabetic cardiomyopathy.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"3,1,0\"\u003eImplement guideline-directed medical therapies using GLP-1 RAs, SGLT2 inhibitors, and novel MRAs to optimize cardio-renal protection in patients with diabetes.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"3,2,0\"\u003eAnalyze the systemic impact of sleep disorders, hypercortisolism, and women-specific risk factors on cardiovascular and metabolic health.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"3,3,0\"\u003eAssess the latest cardiovascular outcome trials (CVOTs) and integrate emerging lipid-lowering treatments targeting ApoB and CETP into clinical practice.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"3,4,0\"\u003eApply digital health technologies, intensive lifestyle interventions, and multidisciplinary approaches to manage complex cases involving obesity and heart failure.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2 data-path-to-node=\"4\"\u003e3. Target Audience\u003c\/h2\u003e\n\u003cp\u003eBest for cardiologists, endocrinologists, and nephrologists who want updates on cardiorenal metabolic therapies, clinical trials, and obesity.\u003c\/p\u003e\n\u003ch2 data-path-to-node=\"6\"\u003e4. Topics\u003c\/h2\u003e\n\u003cul data-path-to-node=\"8\"\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,0,0\"\u003eDay 1 01 Epidemiology and Pathophysiology of Resistant Hypertension and CKD Treatment\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,1,0\"\u003eDay 1 02 Management of Chronic Kidney Disease With or Without Albuminuria\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,2,0\"\u003eDay 1 03 Emerging Approaches to the Treatment of Resistant Hypertension\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,3,0\"\u003eDay 1 04 Case Presentation – Treatment Resistant Hypertension\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,4,0\"\u003eDay 1 05 Cortisol – Impact on Endocrinology \u0026amp; Metabolism\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,5,0\"\u003eDay 1 06 Cortisol’s Impact on the Kidney-BP-Bone\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,6,0\"\u003eDay 1 07 Cardiovascular Implications of Hypercortisolism\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,7,0\"\u003eDay 1 08 Panel Discussion and Q\u0026amp;A – Cortisol \u0026amp; Cardiorenalmetabolic Diseases\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,8,0\"\u003eDay 1 09 MASLD and MASH – Pathophysiology, Diagnosis and Management\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,9,0\"\u003eDay 1 10 Sleep Health – Implications for Obesity and Diabetes Risk\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,10,0\"\u003eDay 1 11 Sleep and Cardiovascular Risk\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,11,0\"\u003eDay 1 12 Panel Discussion and Q\u0026amp;A – Sleep Disorders in Cardiometabolism\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,12,0\"\u003eDay 1 13 Prediabetes – What’s a Clinician to Do\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,13,0\"\u003eDay 1 14 Unraveling the Connection – Diabetes and Dementia\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,14,0\"\u003eDay 1 15 Pulmonary Disorders in Diabetes – Implications for Heart Disease\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,15,0\"\u003eDay 1 16 Diabetes and Cardiovascular Disease in Older Adults\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,16,0\"\u003eDay 1 17 Panel Discussion and Q\u0026amp;A – Diabetes Comorbidities\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,17,0\"\u003eDay 1 18 Implementing Guideline-Directed Medical Therapy – Stakeholder-Identified Barriers and Facilitators\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,18,0\"\u003eDay 1 19 Population Health Approaches to Accelerate the Prevention of CVD – Moving from Action to Impact\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,19,0\"\u003eDay 1 20 Panel Discussion and Q\u0026amp;A – Implementation Science in Practice\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,20,0\"\u003eDay 1 21 Dyslipidemia in Women Across a Lifetime Approach to Management\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,21,0\"\u003eDay 1 22 Sex Hormones and Anthropometric Measures \u0026amp; Heart Failure Risk in Women\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,22,0\"\u003eDay 1 23 Panel Discussion and Q\u0026amp;A – Women’s Health\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,23,0\"\u003eDay 1 24 Cardiovascular, Kidney, and Safety Outcomes With GLP-1 Receptor Agonists Alone or In Combination With SGLT2 Inhibit…\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,24,0\"\u003eDay 1 25 Optimal Strategy for Heart Failure Screening Among Adults With Diabetes Without ASCVD – A Pooled Cohort Analysis\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,25,0\"\u003eDay 1 26 Mineralocorticoid Receptor Antagonism Prevents Aortic Plaque Progression and Reduces Left Ventricular Mass and Fibro…\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,26,0\"\u003eDay 1 27 Accelerated Risk-Based Implementation of Guideline-Directed Medical Therapy for Chronic Kidney Disease\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,27,0\"\u003eDay 1 28 Panel Discussion and Q\u0026amp;A – Circulation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,28,0\"\u003eDay 2 01 Current Trends in Epidemiology of Heart Failure – USA\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,29,0\"\u003eDay 2 02 Diabetic Cardiomyopathy – Mechanisms and Future Directions\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,30,0\"\u003eDay 2 03 Bromocriptine in the Treatment of Peripartum Cardiomyopathy – Is It Ready for Prime Time\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,31,0\"\u003eDay 2 04 Proper Medical Management of HFpEF in 2025\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,32,0\"\u003eDay 2 05 Panel Discussion and Q\u0026amp;A – Heart Failure – The Now \u0026amp; The New\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,33,0\"\u003eDay 2 06 GLP1-RA, Obesity \u0026amp; Diabetes – Mechanisms of Cardiovascular Protection\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,34,0\"\u003eDay 2 07 Cardio-Kidney Protection With Incretin Therapies\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,35,0\"\u003eDay 2 08 Incretins – Today and Tomorrow\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,36,0\"\u003eDay 2 09 Panel Discussion and Q\u0026amp;A – Current \u0026amp; Future Role of Incretin Therapy\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,37,0\"\u003eDay 2 10 Diabetes and Cardiovascular Disease – The Evolution of CV Outcomes Assessment of Antihyperglycemic Medications\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,38,0\"\u003eDay 2 11 My Personal Journey to HoFH Diagnosis\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,39,0\"\u003eDay 2 12 From Rare to the Very Common – Role of Genetics in Lipid Disorders\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,40,0\"\u003eDay 2 13 CETPi – Where Might They Fit Into Clinical Practice\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,41,0\"\u003eDay 2 14 Using ApoB in Clinical Practice – From Risk Assessment to Treatment Targets\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,42,0\"\u003eDay 2 15 Obesity and Dyslipidemia – Can We Finally Break the Cycle With Dual Agonists\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,43,0\"\u003eDay 2 16 The Epidemiology and Pathophysiology of Cardio-Kidney-Metabolic Diseases\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,44,0\"\u003eDay 2 17 Unmet Needs in CKD in T1D and Challenges in CKD Beyond Diabetes\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,45,0\"\u003eDay 2 18 Finerenone Across the Stages of Heart Failure – From Prevention to Treatment\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,46,0\"\u003eDay 2 19 Panel Discussion and Q\u0026amp;A – Cardio-Renal Protection in CKM Diseases\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,47,0\"\u003eDay 2 20 Digital Health Technologies for Cardiometabolic Disease \u0026amp; Diabetes\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,48,0\"\u003eDay 2 21 Food Is Medicine Strategies for Nutrition Security \u0026amp; Cardiometabolic Health Equity – JACC State-of-the-Art Review\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,49,0\"\u003eDay 2 22 Intensive Lifestyle Intervention, Cardiac Biomarkers, and Cardiovascular Outcomes in Diabetes – The Look AHEAD Cardiac…\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,50,0\"\u003eDay 2 23 Racial Differences in Diabetic Cardiomyopathy – Results From the Phase 3 Randomized Controlled ARISE-HF Study\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,51,0\"\u003eDay 2 24 Panel Discussion and Q\u0026amp;A – JACC\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,52,0\"\u003eDay 2 25 Technology in the Management of Diabetes – Addressing Its Role in Comorbidities\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,53,0\"\u003eDay 2 26 SGLT2 Inhibitors – Reconsidering, Repurposing, Reimagining\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,54,0\"\u003eDay 2 27 Panel Discussion and Q\u0026amp;A – Diabetes Management \u0026amp; Technology\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,55,0\"\u003eDay 3 01 Management of Complex Cases – Obesity and Heart Failure\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,56,0\"\u003eDay 3 02 The Edema Dilemma – A Case of Diabetes Mellitus, Heart Failure With Preserved Ejection Fraction, Obesity, Chronic Kidne…\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,57,0\"\u003eDay 3 03 CRM Management of Complex Cases\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,58,0\"\u003eDay 3 04 The Lancet Commission on Obesity\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,59,0\"\u003eDay 3 05 Obesity – Role of Medical Management\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,60,0\"\u003eDay 3 06 Management of Obesity Addressing Lean Mass Preservation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,61,0\"\u003eDay 3 07 Panel Discussion and Q\u0026amp;A – Obesity\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,62,0\"\u003eDay 3 08 Do ACEiARB Still Have a Role in the Era of SGLT2, MRA and GLP1A\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,63,0\"\u003eDay 3 09 The Role of Diastolic \u0026amp; Pulse Pressure in CKD \u0026amp; CVD – Management Considerations\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,64,0\"\u003eDay 3 10 Aldosterone – The Forgotten Hormone in Hypertension\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,65,0\"\u003eDay 3 11 Panel Discussion and Q\u0026amp;A – The Kidney and Hypertension\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,66,0\"\u003eDay 3 12 Combination Treatment to Improve Heart and Kidney Outcomes in Diabetic Kidney Disease\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,67,0\"\u003eDay 3 13 The Latest Heart Disease \u0026amp; Stroke Statistics – US \u0026amp; Global Data from the American Heart Association\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,68,0\"\u003eDay 3 14 Appropriate Cardiac Intervention in the Diabetes Cardiorenal \u0026amp; Metabolic Medicine Patient\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,69,0\"\u003eDay 3 15 Serum Lipoproteins \u0026amp; Coronary Atherosclerosis in Asymptomatic U.S. Adults Without Traditional Risk Factors\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,70,0\"\u003eDay 3 16 Cardiovascular Outcome Trials Update\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"8,71,0\"\u003eDay 3 17 Panel Discussion and Q\u0026amp;A – ASCVD\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Docebook","offers":[{"title":"Default Title","offer_id":48046937407723,"sku":"MA-30","price":99.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0821\/3105\/8923\/files\/HospitalforSpecialSurgeryContemporaryTopicsinVasculitis2024-2026-04-05T032934.798.png?v=1775355635"},{"product_id":"stress-and-heart-disease-1st-ed-1985-edition","title":"Stress and Heart Disease 1st ed. 1985 Edition","description":"\u003cp\u003e\u003cspan\u003eIt has been known or suspected for centuries that there is an association between mind and emotions and the occurrence of heart disease apd sudden death. During the past fifty years this relationship has become identified with the concept of Stress, a notion developed and popularized by Hans Selye. In recent years there has been an upward surge of interest in stress by scientists in several disciplines and by the general public. Although, books, journal articles, seminars and media programs devoted to stress now abound, the definition, manifestations, mechanisms, and management of stress remain uncertain and controversial. In an attempt to clarify the situation an International Symposium on Stress and Heart Disease was held in Winnipeg, Canada, June 26-29, 1984, and the proceedings form the basis of this book and its companion volume \"Patho­ genesis of Stress-Induced Heart Disease\". Although most species which have ever existed are now extinct through countless millenia, the human species has successfully adapted to changing conditions (\"stressors\") such as ice ages, predators and parasites, wars, famine and plague, and now it is coping with rapidly changing social, economic and political circumstances. Such adaptation occurs at all levels of life- at the molecular level within the cell, at the level of the whole cell, in the groups of cells as organs, in the entire organism or individual, and in some cases, in the society in which the individual lives.\u003c\/span\u003e\u003c\/p\u003e\n\u003chr aria-hidden=\"true\" class=\"a-divider-normal bucketDivider\"\u003e\n\u003ch2\u003eProduct details\u003c\/h2\u003e\n\u003cdiv id=\"detailBullets_feature_div\"\u003e\n\u003cul class=\"a-unordered-list a-nostyle a-vertical a-spacing-none detail-bullet-list\"\u003e\n\u003cli\u003e\u003cspan class=\"a-list-item\"\u003e\u003cspan class=\"a-text-bold\"\u003ePublisher ‏ : ‎\u003cspan\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cspan\u003eSpringer\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan class=\"a-list-item\"\u003e\u003cspan class=\"a-text-bold\"\u003ePublication date ‏ : ‎\u003cspan\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cspan\u003eOctober 1, 2011\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan class=\"a-list-item\"\u003e\u003cspan class=\"a-text-bold\"\u003eEdition ‏ : ‎\u003cspan\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cspan\u003eSoftcover reprint of the original 1st ed. 1985\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan class=\"a-list-item\"\u003e\u003cspan class=\"a-text-bold\"\u003eLanguage ‏ : ‎\u003cspan\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cspan\u003eEnglish\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan class=\"a-list-item\"\u003e\u003cspan class=\"a-text-bold\"\u003ePrint length ‏ : ‎\u003cspan\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cspan\u003e463 pages\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan class=\"a-list-item\"\u003e\u003cspan class=\"a-text-bold\"\u003eISBN-10 ‏ : ‎\u003cspan\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cspan\u003e1461296226\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan class=\"a-list-item\"\u003e\u003cspan class=\"a-text-bold\"\u003eISBN-13 ‏ : ‎\u003cspan\u003e \u003c\/span\u003e\u003c\/span\u003e\u003cspan\u003e978-1461296225\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e","brand":"Springer","offers":[{"title":"Default Title","offer_id":48047506850027,"sku":"AN0","price":29.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0821\/3105\/8923\/files\/HospitalforSpecialSurgeryContemporaryTopicsinVasculitis2024-2026-04-05T145936.976.png?v=1775397057"},{"product_id":"scripps-cardiovascular-atherosclerosis-prediction-prevention-and-management-2025","title":"Scripps Cardiovascular Atherosclerosis Prediction, Prevention and Management 2025","description":"\u003ch3\u003eScripps Cardiovascular Atherosclerosis Prediction, Prevention and Management 2025\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003e Include: 16 videos + 13 pdfs, size: 4.02 GB\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTarget Audience: cardiologists, internists, preventive medicine specialists\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e Information:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCardiovascular Atherosclerosis: Prediction, Prevention and Management\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMay 17, 2025 • San Diego Marriott • La Jolla, California\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eConference Overview\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDespite notable advances in management, atherosclerotic cardiovascular disease (ASCVD) and its major clinical manifestations remains a leading cause of both morbidity and mortality worldwide.\u003c\/p\u003e\n\u003cp\u003eIn the United States alone, ASCVD is the leading cause of death in most racial and ethnic populations and is estimated to cost more than $200 billion per year due to medications, healthcare service utilization, and productivity losses. Many of these human and economic costs are largely attributable to poor implementation of prevention strategies in adults and failure to control ASCVD risk factors using available medications\u003cbr\u003eand lifestyle interventions. The Scripps Cardiovascular Atherosclerosis conference is designed to assist clinicians in the prevention, diagnosis, treatment, and ongoing management of ASCVD among patients in their clinical practices, as well as to promote increased awareness of prudent lifestyle and dietary choices to improve patient outcomes.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEducational Objectives\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAfter attending this live activity, participants should be able to:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eIdentify effective treatments, including lifestyle modifications, for managing atherosclerotic cardiovascular disease (ASCVD).\u003c\/li\u003e\n\u003cli\u003eEvaluate current guideline-directed medical therapy (GDMT) options and emerging strategies for managing cardiovascular disease.\u003c\/li\u003e\n\u003cli\u003eIdentify the unique risk factors, symptoms, and treatment considerations associated with cardiovascular disease in women.\u003c\/li\u003e\n\u003cli\u003eDescribe novel treatment approaches and assess the role of renal denervation in the management of treatment-resistant hypertension.\u003c\/li\u003e\n\u003cli\u003eIncorporate evidence-based practices in clinical settings for diagnosing, managing, and treating peripheral artery disease.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe Scripps \u003cem\u003eCardiovascular Atherosclerosis: Prediction, Prevention and Management 2025\u003c\/em\u003e symposium is best for cardiologists, internists, preventive medicine specialists, and allied health professionals who want updates on risk assessment, prevention strategies, and management of atherosclerotic cardiovascular disease.\u003c\/p\u003e\n\u003ch3\u003e👩⚕️ Who Should Attend\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eCardiologists (general and interventional) managing patients with coronary artery disease and vascular risk.\u003c\/li\u003e\n\u003cli\u003eInternists and family physicians providing frontline preventive care for cardiovascular disease.\u003c\/li\u003e\n\u003cli\u003ePreventive medicine specialists focusing on risk factor modification and population health.\u003c\/li\u003e\n\u003cli\u003eEndocrinologists managing diabetes and metabolic syndrome as major contributors to atherosclerosis.\u003c\/li\u003e\n\u003cli\u003eNurse practitioners, physician assistants, and pharmacists involved in cardiovascular risk management.\u003c\/li\u003e\n\u003cli\u003eResidents and fellows in cardiology or internal medicine preparing for board exams or subspecialty practice.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e📚 What You’ll Learn\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eRisk prediction tools: emerging biomarkers, imaging modalities, and genetic risk assessment.\u003c\/li\u003e\n\u003cli\u003ePrevention strategies: lifestyle interventions, lipid management, hypertension control, and diabetes care.\u003c\/li\u003e\n\u003cli\u003ePharmacologic therapies: statins, PCSK9 inhibitors, anti‑inflammatory agents, and novel drugs.\u003c\/li\u003e\n\u003cli\u003eManagement of established disease: secondary prevention, revascularization, and long‑term outcomes.\u003c\/li\u003e\n\u003cli\u003eCase‑based discussions: practical approaches to complex patients with multiple risk factors.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTopics:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSaturday, May 17, 2025\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e6:45 a.m. Registration, Breakfast \u0026amp; View Exhibits\u003c\/li\u003e\n\u003cli\u003e7–7:55 a.m. Non-CME Breakfast Symposium Hosted by AstraZeneca\u003c\/li\u003e\n\u003cli\u003e7:55 a.m. Welcome \u0026amp; Introductions David Cork, MD and Christopher Suhar, MD\u003c\/li\u003e\n\u003cli\u003e8 a.m. LDL-Cholesterol: Ideal Targets. How Low is too Low? Nicholas Marston, MD\u003c\/li\u003e\n\u003cli\u003e8:30 a.m. Non-Statin Therapies: Deep Dive Pam Taub, MD\u003c\/li\u003e\n\u003cli\u003e9 a.m. Cardiometabolic Health: The Risk of Obesity and Pharmacotherapy Review Lauren Vincent, MD\u003c\/li\u003e\n\u003cli\u003e9:30 a.m. Panel Discussion\/Q\u0026amp;A\u003c\/li\u003e\n\u003cli\u003e9:45 a.m. Break \u0026amp; View Exhibits\u003c\/li\u003e\n\u003cli\u003e10:15 a.m. Resistant Hypertension Management: Current and Future Pharmacotherapies and Renal Denervation David Cork, MD\u003c\/li\u003e\n\u003cli\u003e10:45 a.m. Diagnostic Testing for Obstructive CAD: Which Modality to Choose? Matthew Budoff, MD\u003c\/li\u003e\n\u003cli\u003e11:15 a.m. Cardiovascular Disease in Women: An Update Martha Gulati, MD\u003c\/li\u003e\n\u003cli\u003e11:45 a.m. Panel Discussion\/Q\u0026amp;A\u003c\/li\u003e\n\u003cli\u003eNoon Non-CME Lunch Symposium Hosted by Novartis Pharmaceuticals Little Particle, Big Impact: Exploring Lp(a) From a Perspective of a Patient With a Premature ASCVD Event Dan Luu, PharmD, BCPS\u003c\/li\u003e\n\u003cli\u003e1 p.m. Atrial Fibrillation Management: Introducing Pulsed Field Ablation Nicholas Olson, MD\u003c\/li\u003e\n\u003cli\u003e1:30 p.m. Atrial Fibrillation Management: Anticoagulation or Left Atrial Appendage Occlusion? Douglas Gibson, MD\u003c\/li\u003e\n\u003cli\u003e2 p.m. Diet and Exercise: Counsel Your Patients More Effectively Christopher Suhar, MD\u003c\/li\u003e\n\u003cli\u003e2:30 p.m. Panel Discussion\/Q\u0026amp;A\u003c\/li\u003e\n\u003cli\u003e2:45 p.m. Break \u0026amp; View Exhibits\u003c\/li\u003e\n\u003cli\u003e3 p.m. The Best Biomarkers to Assess Atherosclerotic Risk P. Barton Duell, MD\u003c\/li\u003e\n\u003cli\u003e3:30 p.m. Peripheral Artery Disease Update Curtiss Stinis, MD\u003c\/li\u003e\n\u003cli\u003e4 p.m. Diagnostic Evaluation and Management of Coronary Vasospasm and Endothelial Dysfunction Matthew Price, MD\u003c\/li\u003e\n\u003cli\u003e4:30 p.m. Panel Discussion\/Q\u0026amp;A\u003c\/li\u003e\n\u003cli\u003e4:45 p.m. Adjourn Topics, times, and speakers are subject to change.\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Docebook","offers":[{"title":"Default Title","offer_id":48047777743083,"sku":"MA-50","price":119.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0821\/3105\/8923\/files\/HospitalforSpecialSurgeryContemporaryTopicsinVasculitis2024-2026-04-05T202438.940.png?v=1775416579"},{"product_id":"early-vascular-aging-eva-new-directions-in-cardiovascular-protection-2nd-edition-pdf","title":"Early Vascular Aging (EVA): New Directions in Cardiovascular Protection, 2nd Edition (PDF)","description":"\u003cp data-start=\"303\" data-end=\"719\"\u003e\u003cstrong data-start=\"303\" data-end=\"346\"\u003eEarly Vascular Aging (EVA), 2nd Edition\u003c\/strong\u003e is the definitive resource on premature alterations in arterial structure and function, offering a fresh perspective on cardiovascular disease prevention and treatment. Authored by an international team of leading clinicians and researchers, this edition presents updated, evidence-based content bridging basic science, translational research, and clinical applications.\u003c\/p\u003e\n\u003cp data-start=\"721\" data-end=\"1440\"\u003e\u003cstrong data-start=\"721\" data-end=\"737\"\u003eKey Features\u003c\/strong\u003e\u003cbr data-start=\"737\" data-end=\"740\"\u003e• \u003cstrong data-start=\"742\" data-end=\"769\"\u003eComprehensive Coverage:\u003c\/strong\u003e Explores the causes, consequences, and mechanisms of arterial stiffening and EVA\u003cbr data-start=\"850\" data-end=\"853\"\u003e• \u003cstrong data-start=\"855\" data-end=\"881\"\u003eCutting-Edge Research:\u003c\/strong\u003e Reviews the latest evidence from basic biology, epidemiology, and clinical studies\u003cbr data-start=\"964\" data-end=\"967\"\u003e• \u003cstrong data-start=\"969\" data-end=\"995\"\u003eClinical Applications:\u003c\/strong\u003e Highlights strategies for prevention, diagnosis, and treatment of EVA\u003cbr data-start=\"1065\" data-end=\"1068\" data-is-only-node=\"\"\u003e• \u003cstrong data-start=\"1070\" data-end=\"1092\"\u003eResearch Guidance:\u003c\/strong\u003e Each chapter identifies key unanswered questions, encouraging collaboration and future investigations\u003cbr data-start=\"1194\" data-end=\"1197\"\u003e• \u003cstrong data-start=\"1199\" data-end=\"1220\"\u003eGlobal Expertise:\u003c\/strong\u003e Insights from leading international clinicians and scientists in cardiovascular research\u003cbr data-start=\"1309\" data-end=\"1312\"\u003e• \u003cstrong data-start=\"1314\" data-end=\"1342\"\u003eAuthoritative \u0026amp; Updated:\u003c\/strong\u003e Fully revised content, reflecting paradigm shifts and new directions in vascular aging research\u003c\/p\u003e\n\u003cp data-start=\"1442\" data-end=\"1629\"\u003eA must-have reference for clinicians, researchers, and scientists seeking a deep, authoritative understanding of early vascular aging and its implications for cardiovascular protection.\u003c\/p\u003e\n\u003ch2 class=\"tab-heading\"\u003eSpecification\u003c\/h2\u003e\n\u003cdiv class=\"akf-det-table\"\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003cth\u003ePublished Year\u003c\/th\u003e\n\u003ctd\u003e2024\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eLanguage\u003c\/th\u003e\n\u003ctd\u003e‎English\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003ePublisher\u003c\/th\u003e\n\u003ctd\u003eElsevier\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eEdition :\u003c\/th\u003e\n\u003ctd\u003e2\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eFormat :\u003c\/th\u003e\n\u003ctd\u003ePublisher PDF\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eFile Size :\u003c\/th\u003e\n\u003ctd\u003e45.2\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e","brand":"Elsevier","offers":[{"title":"Default Title","offer_id":48050332565739,"sku":"AB-10","price":39.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0821\/3105\/8923\/files\/HospitalforSpecialSurgeryContemporaryTopicsinVasculitis2024-2026-04-06T153703.214.png?v=1775485867"},{"product_id":"hypertension-secrets-2nd-edition-pdf","title":"Hypertension Secrets, 2nd edition (PDF)","description":"\u003cp data-start=\"203\" data-end=\"522\"\u003e\u003cstrong data-start=\"203\" data-end=\"240\"\u003eHypertension Secrets, 2nd Edition\u003c\/strong\u003e is your concise, practical guide to understanding, diagnosing, and managing hypertension. Part of the acclaimed Secrets Series®, this edition delivers essential information in a clear, question-and-answer format, making review and quick reference simple, efficient, and engaging.\u003c\/p\u003e\n\u003cp data-start=\"524\" data-end=\"1226\"\u003e\u003cstrong data-start=\"524\" data-end=\"540\"\u003eKey Features\u003c\/strong\u003e\u003cbr data-start=\"540\" data-end=\"543\"\u003e• \u003cstrong data-start=\"545\" data-end=\"560\"\u003eQ\u0026amp;A Format:\u003c\/strong\u003e Popular Secrets style allows for fast learning and quick recall\u003cbr data-start=\"624\" data-end=\"627\"\u003e• \u003cstrong data-start=\"629\" data-end=\"656\"\u003eComprehensive Coverage:\u003c\/strong\u003e Pathophysiology, natural history, diagnosis, and management of hypertension\u003cbr data-start=\"732\" data-end=\"735\"\u003e• \u003cstrong data-start=\"737\" data-end=\"760\"\u003eUpdated Guidelines:\u003c\/strong\u003e Fully revised to include the latest protocols and best practices\u003cbr data-start=\"825\" data-end=\"828\" data-is-only-node=\"\"\u003e• \u003cstrong data-start=\"830\" data-end=\"849\"\u003eSpecial Topics:\u003c\/strong\u003e Obstructive sleep apnea, drug- or alcohol-induced hypertension, hypertension in diabetes, obesity, pregnancy, the elderly, African Americans, thyroid disorders, and device therapy\u003cbr data-start=\"1029\" data-end=\"1032\"\u003e• \u003cstrong data-start=\"1034\" data-end=\"1067\"\u003eTop 100 Secrets \u0026amp; Key Points:\u003c\/strong\u003e Quick overview of must-know information for exams and clinical practice\u003cbr data-start=\"1139\" data-end=\"1142\"\u003e• \u003cstrong data-start=\"1144\" data-end=\"1168\"\u003eConcise \u0026amp; Practical:\u003c\/strong\u003e Bulleted lists, mnemonics, and tips from global experts\u003c\/p\u003e\n\u003cp data-start=\"1228\" data-end=\"1375\"\u003ePerfect for students, residents, and practicing clinicians, this guide provides rapid, high-yield knowledge to excel in exams and daily practice.\u003c\/p\u003e\n\u003ch2 class=\"tab-heading\"\u003eSpecification\u003c\/h2\u003e\n\u003cdiv class=\"akf-det-table\"\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003cth\u003eLanguage\u003c\/th\u003e\n\u003ctd\u003e‎English\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003ePublisher\u003c\/th\u003e\n\u003ctd\u003eElsevier\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eEdition :\u003c\/th\u003e\n\u003ctd\u003e2\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eFormat :\u003c\/th\u003e\n\u003ctd\u003eTrue PDF (No Index \u0026amp; ToC)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eFile Size :\u003c\/th\u003e\n\u003ctd\u003e15.5\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e","brand":"Elsevier","offers":[{"title":"Default Title","offer_id":48050338857195,"sku":"AN0","price":25.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0821\/3105\/8923\/files\/HospitalforSpecialSurgeryContemporaryTopicsinVasculitis2024-2026-04-06T155505.193.png?v=1775486790"},{"product_id":"the-esc-textbook-of-preventive-cardiology-clinical-practice-1st-edition","title":"The ESC Textbook of Preventive Cardiology: Clinical practice 1st Edition","description":"\u003cp data-start=\"138\" data-end=\"605\"\u003e\u003cem data-start=\"138\" data-end=\"200\"\u003eThe ESC Textbook of Preventive Cardiology: Clinical Practice\u003c\/em\u003e is a practical, evidence-based guide for healthcare professionals aiming to prevent cardiovascular disease. Aligned with the 2012 Joint European Guidelines and recommendations from the European Association of Cardiac Prevention and Rehabilitation, it provides clear, actionable strategies for patient identification, risk assessment, lifestyle modification, medication adherence, and family engagement.\u003c\/p\u003e\n\u003cp data-start=\"607\" data-end=\"986\"\u003eFully revised and updated from its previous edition, this handbook includes checklists, diagrams, and risk estimation charts, along with guidance on health promotion workshops and supervised exercise programs. Concise and accessible, it equips clinicians with the tools and skills needed to implement effective cardiovascular disease prevention in real-world clinical practice.\u003c\/p\u003e\n\u003cp data-start=\"988\" data-end=\"1007\"\u003e\u003cstrong data-start=\"988\" data-end=\"1005\"\u003eKey Features:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-start=\"1008\" data-end=\"1489\"\u003e\n\u003cli data-section-id=\"1gcm4b9\" data-start=\"1008\" data-end=\"1133\"\u003e\n\u003cstrong data-start=\"1010\" data-end=\"1030\"\u003ePractical Focus:\u003c\/strong\u003e Step-by-step guidance from patient identification to lifestyle management and medication compliance.\u003c\/li\u003e\n\u003cli data-section-id=\"1s6x51h\" data-start=\"1134\" data-end=\"1220\"\u003e\n\u003cstrong data-start=\"1136\" data-end=\"1155\"\u003eEvidence-Based:\u003c\/strong\u003e Aligned with ESC guidelines and best practice recommendations.\u003c\/li\u003e\n\u003cli data-section-id=\"jeta00\" data-start=\"1221\" data-end=\"1311\"\u003e\n\u003cstrong data-start=\"1223\" data-end=\"1240\"\u003eVisual Tools:\u003c\/strong\u003e Checklists, diagrams, and risk estimation charts for easy reference.\u003c\/li\u003e\n\u003cli data-section-id=\"1h1j07f\" data-start=\"1312\" data-end=\"1407\"\u003e\n\u003cstrong data-start=\"1314\" data-end=\"1339\"\u003eClinical Application:\u003c\/strong\u003e Includes guidance for workshops and supervised exercise programs.\u003c\/li\u003e\n\u003cli data-section-id=\"13chaeh\" data-start=\"1408\" data-end=\"1489\"\u003e\n\u003cstrong data-start=\"1410\" data-end=\"1430\"\u003eUpdated Edition:\u003c\/strong\u003e Fully revised for modern preventive cardiology practice.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2 class=\"tab-heading\"\u003eSpecification\u003c\/h2\u003e\n\u003cdiv class=\"akf-det-table\"\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003cth\u003eLanguage\u003c\/th\u003e\n\u003ctd\u003e‎English\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003ePublisher\u003c\/th\u003e\n\u003ctd\u003eOxford University Press\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eEdition :\u003c\/th\u003e\n\u003ctd\u003e1\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eISBN :\u003c\/th\u003e\n\u003ctd\u003e9780199674039\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e","brand":"Oxford University Press","offers":[{"title":"Default Title","offer_id":48054371090667,"sku":"AN-0","price":29.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0821\/3105\/8923\/files\/HospitalforSpecialSurgeryContemporaryTopicsinVasculitis2024-2026-04-07T204249.794.png?v=1775590464"},{"product_id":"endothelium-and-cardiovascular-diseases-vascular-biology-and-clinical-syndromes-2nd-edition-pdf","title":"Endothelium and Cardiovascular Diseases: Vascular Biology and Clinical Syndromes, 2nd Edition (PDF)","description":"\u003cp\u003eBy Protasio L. Da Luz MD FACC, Peter Libby MD PhD, Antonio Carlos Palandri Chagas, Francisco Rafael Martins Laurindo\u003c\/p\u003e\n\u003cp\u003eEndothelium and Cardiovascular Diseases: Vascular Biology and Clinical Syndromes, Second Edition offers new discoveries in clinical settings, cellular, molecular, genetic, and epigenetic mechanisms which have led to novel understanding of the key role of endothelium in both cardiovascular and non-cardiovascular diseases. The innovations it presents have implications for both pathophysiological concepts and clinical decisions. Among other topics, cardiovascular and pulmonary medicine, immunity and inflammation, genetics and epigenetics, heart failure, renal disease, familial hypercholesterolemia, diabetes, and hypertension are discussed at length.With 20 new chapters covering everything from endothelium transition to connective tissue disorders, this second edition is sure to be indispensable to anyone wishing to learn the importance of endothelium to every facet of health.\u003c\/p\u003e\n\u003cul class=\"a-unordered-list a-vertical\"\u003e\n\u003cli\u003eExamines the ways in which endothelium relates to almost every cardiovascular and systemic disease\u003c\/li\u003e\n\u003cli\u003eProvides a critical, in depth, pathophysiological review of endothelium which cannot be found in any other single volume\u003c\/li\u003e\n\u003cli\u003eOffers cutting-edge, critical knowledge for investigators and practitioners alike, information which has evolved rapidly since the previous edition\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2 class=\"tab-heading\"\u003eSpecification\u003c\/h2\u003e\n\u003cdiv class=\"akf-det-table\"\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003cth\u003ePublished Year\u003c\/th\u003e\n\u003ctd\u003e2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eLanguage\u003c\/th\u003e\n\u003ctd\u003e‎English\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003ePublisher\u003c\/th\u003e\n\u003ctd\u003eElsevier\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eEdition :\u003c\/th\u003e\n\u003ctd\u003e2\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eFormat :\u003c\/th\u003e\n\u003ctd\u003e PDF\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eFile Size :\u003c\/th\u003e\n\u003ctd\u003e62.2\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e","brand":"Elsevier","offers":[{"title":"Default Title","offer_id":48080283828459,"sku":"AB-20","price":59.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0821\/3105\/8923\/files\/HospitalforSpecialSurgeryContemporaryTopicsinVasculitis2024-2026-04-11T142732.955.png?v=1775913596"},{"product_id":"platelets-in-disease-thrombotic-disorders-and-disorders-not-involving-hemorrhage-or-thrombosis-pdf","title":"Platelets in Disease: Thrombotic Disorders and Disorders not Involving Hemorrhage or Thrombosis (PDF)","description":"\u003cp\u003e\u003cstrong\u003eby Paolo Gresele (ed.), José A. López (ed.), Dominick J. Angiolillo (ed.), Clive P. Page (ed.)\u003c\/strong\u003e\u003c\/p\u003e\n\u003cdiv\u003e\n\u003cp\u003e\u003cspan\u003eThis five-volume series provides clinicians with a detailed, up-to-date, well-referenced overview of the latest developments in this rapidly expanding feld. It serves as an\u003cbr\u003eauthoritative guide to the diagnosis and treatment of platelet disorders.The primary audience for the series is clinicians, residents and fellows in internal medicine,\u003cbr\u003ecardiology and haematology, as well as clinicians (e.g. neurologists, nephrologists, rheumatologists) and basic scientists who may be concerned with disorders and\u003cbr\u003ecellular mechanisms involving platelets.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch2 class=\"tab-heading\"\u003eSpecification\u003c\/h2\u003e\n\u003cdiv class=\"akf-det-table\"\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003cth\u003ePublished Year\u003c\/th\u003e\n\u003ctd\u003e2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eLanguage\u003c\/th\u003e\n\u003ctd\u003e‎English\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003ePublisher\u003c\/th\u003e\n\u003ctd\u003eSpringer\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eEdition :\u003c\/th\u003e\n\u003ctd\u003e1\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eFormat :\u003c\/th\u003e\n\u003ctd\u003ePDF\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eFile Size :\u003c\/th\u003e\n\u003ctd\u003e69.4\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Springer","offers":[{"title":"Default Title","offer_id":48080291365099,"sku":"ANA-0-AB-6","price":35.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0821\/3105\/8923\/files\/HospitalforSpecialSurgeryContemporaryTopicsinVasculitis2024-2026-04-11T143527.923.png?v=1775914056"},{"product_id":"cardiovascular-physiology-concepts-3rd-edition-pdf","title":"Cardiovascular Physiology Concepts, 3rd edition (PDF)","description":"\u003cdiv id=\"bylineInfo\" class=\"a-section a-spacing-micro bylineHidden feature\"\u003e\n\u003cp\u003eby\u003c\/p\u003e\n\u003cdiv id=\"a-popover-contributor-info-B08PVWYVXL\" class=\"a-popover-preload\"\u003e\n\u003cdiv class=\"a-section\"\u003e\n\u003ctable class=\"a-normal\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd id=\"contributorImageContainerB08PVWYVXL\"\u003e\u003c\/td\u003e\n\u003ctd class=\"a-size-base\"\u003e\n\u003cdiv class=\"a-row\"\u003e\u003cspan class=\"a-size-medium\"\u003eDr. Richard E. Klabunde PhD\u003cspan class=\"a-color-secondary\"\u003e(Author)\u003c\/span\u003e\u003c\/span\u003e\u003c\/div\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cp\u003ePraised for its concise coverage, this highly accessible monograph lays a foundation for understanding the underlying concepts of normal cardiovascular function and offers a welcome alternative to a more mechanistically oriented approach or an encyclopedic physiology text. Clear explanations, ample illustrations and engaging clinical cases and problems provide the perfect guidance for self-directed learning and prepare you to excel in clinical practice.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003eChapter Learning Objectives\u003c\/b\u003e\u003cspan\u003e \u003c\/span\u003ehighlight key concepts at a glance.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eProblems and Clinical Cases with Answers to Problems\u003c\/b\u003e\u003cspan\u003e \u003c\/span\u003ereinforce fundamental physiological concepts.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eSummary of Important Concepts\u003c\/b\u003e\u003cspan\u003e \u003c\/span\u003eboxes provide bulleted quick-review of essential chapter content.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eMultiple-choice Review Questions and Answers to Review Questions\u003c\/b\u003e\u003cspan\u003e \u003c\/span\u003e(with full explanations for each answer choice) enable self-assessment and alert you to areas requiring further study.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eA chapter\u003cspan\u003e \u003c\/span\u003e\u003c\/b\u003e\u003cb\u003eon\u003cspan\u003e \u003c\/span\u003e\u003c\/b\u003e\u003cb\u003eCardiovascular Integration, Adaptation, and Pathophysiology\u003c\/b\u003e\u003cspan\u003e \u003c\/span\u003eintegrates cardiovascular concepts in the context of normal and clinically relevant conditions.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eeBook available.\u003c\/b\u003e\u003cspan\u003e \u003c\/span\u003eFast, smart, and convenient, today’s eBooks can transform learning. These interactive, fully searchable tools offer 24\/7 access on multiple devices, the ability to highlight and share notes, and much more.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2 class=\"tab-heading\"\u003eSpecification\u003c\/h2\u003e\n\u003cdiv class=\"akf-det-table\"\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003cth\u003eLanguage\u003c\/th\u003e\n\u003ctd\u003e‎English\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003ePublisher\u003c\/th\u003e\n\u003ctd\u003eLippincott Williams \u0026amp; Wilkins\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eEdition :\u003c\/th\u003e\n\u003ctd\u003e3\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eFormat :\u003c\/th\u003e\n\u003ctd\u003ePDF\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eFile Size :\u003c\/th\u003e\n\u003ctd\u003e40.9\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eISBN :\u003c\/th\u003e\n\u003ctd\u003e9781975150075\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Lippincott Williams \u0026amp; Wilkins","offers":[{"title":"Default Title","offer_id":48080472670443,"sku":"AB7","price":27.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0821\/3105\/8923\/files\/HospitalforSpecialSurgeryContemporaryTopicsinVasculitis2024-2026-04-11T175305.692.png?v=1775926087"},{"product_id":"handbook-of-cardiovascular-behavioral-medicine-pdf","title":"Handbook of Cardiovascular Behavioral Medicine (PDF)","description":"\u003ch2\u003e\u003cspan style=\"color: rgb(255, 42, 0);\"\u003e\u003cstrong\u003e(PDF ONLY)\u003c\/strong\u003e\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eBy Shari R. Waldstein, Willem J. Kop, Edward C. Suarez, William R. Lovallo, Leslie I. Katzel\u003c\/p\u003e\n\u003cp\u003eCardiovascular disease is the leading cause of morbidity and mortality in the United States and worldwide. It is well recognized that traditional risk factors for cardiovascular disease have limited predictive utility in the identification of new cardiovascular disease cases and outcomes. Thus, investigators have argued that application of a biopsychosocial research paradigm in this field may be of particular utility in understanding cardiovascular disease pathogenesis. Accordingly, a subdiscipline within the field of behavioral medicine – cardiovascular behavioral medicine – examines interrelations among biological, behavioral, psychological, social, and environmental factors in cardiovascular health and disease.\u003c\/p\u003e\n\u003ch2 class=\"tab-heading\"\u003eSpecification\u003c\/h2\u003e\n\u003cdiv class=\"akf-det-table\"\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003cth\u003ePublished Year\u003c\/th\u003e\n\u003ctd\u003e2022\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eLanguage\u003c\/th\u003e\n\u003ctd\u003e‎English\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003ePublisher\u003c\/th\u003e\n\u003ctd\u003eSpringer\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eEdition :\u003c\/th\u003e\n\u003ctd\u003e1\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eFormat :\u003c\/th\u003e\n\u003ctd\u003ePublisher PDF\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eFile Size :\u003c\/th\u003e\n\u003ctd\u003e21.7\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eISBN :\u003c\/th\u003e\n\u003ctd\u003e9780387859590\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e","brand":"Springer","offers":[{"title":"Default Title","offer_id":48080535683307,"sku":"ANA-0","price":39.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0821\/3105\/8923\/files\/HospitalforSpecialSurgeryContemporaryTopicsinVasculitis2024-2026-04-11T185836.170.png?v=1775929863"},{"product_id":"cardiovascular-pathology-5th-edition","title":"Cardiovascular Pathology, 5th Edition (PDF)","description":"\u003cp\u003e\u003ci\u003eCardiovascular Pathology, Fifth Edition\u003c\/i\u003e\u003cspan\u003e \u003c\/span\u003eprovides a comprehensive treatise on the pathology of cardiovascular diseases, combining presentations of detailed pathology of cardiovascular diseases coupled with contemporary insights into etiology and pathogenesis. Twenty-two chapters cover general topics, including cardiovascular genetics, heart failure, and transplantation, and specific congenital and acquired cardiovascular diseases, therapeutic interventions, and forensic aspects. New chapters address the scope of practice and training in cardiovascular pathology, with a focus on major diagnostic approaches used in contemporary practice and research in cardiovascular pathology, and a perspective on the field of cardiovascular regenerative medicine linked to the basic pathobiology of cell-based therapy.\u003c\/p\u003e\n\u003cp\u003eThe book provides a unique combination of details of pathological anatomy essential for pathologists involved in the evaluation of cardiovascular specimens and cardiovascular diseases, and is an excellent reference for anyone interested in the natural history and therapeutic advances in the cardiovascular field.\u003c\/p\u003e\n\u003ch2 class=\"tab-heading\"\u003eSpecification\u003c\/h2\u003e\n\u003cdiv class=\"akf-det-table\"\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003cth\u003eLanguage\u003c\/th\u003e\n\u003ctd\u003e‎English\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003ePublisher\u003c\/th\u003e\n\u003ctd\u003eElsevier\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eEdition :\u003c\/th\u003e\n\u003ctd\u003e5\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eFormat :\u003c\/th\u003e\n\u003ctd\u003ePDF\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eFile Size :\u003c\/th\u003e\n\u003ctd\u003e146.8\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eISBN :\u003c\/th\u003e\n\u003ctd\u003e9780128222249, 9780323912587\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e","brand":"Elsevier","offers":[{"title":"Default Title","offer_id":48080550592747,"sku":"ANA0-AB7","price":35.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0821\/3105\/8923\/files\/HospitalforSpecialSurgeryContemporaryTopicsinVasculitis2024-2026-04-11T191042.510.png?v=1775930497"},{"product_id":"cardiovascular-thrombus-from-pathology-and-clinical-presentations-to-imaging-pharmacotherapy-and-interventions-pdf","title":"Cardiovascular Thrombus: From Pathology and Clinical Presentations to Imaging, Pharmacotherapy and Interventions (PDF)","description":"\u003cp\u003e\u003cstrong\u003eby On Topaz (Editor)\u003c\/strong\u003e\u003cbr\u003eCardiovascular Thrombus: From Pathology and Clinical Presentations to Imaging, Pharmacotherapy and Interventions provides a comprehensive, up-to-date presentation of the research and clinical practices as related to the contemporary aspects of the diagnosis and management of cardiovascular thrombosis. The formation, identification and management of cardiovascular thrombus is of paramount importance for researchers and practicing physicians, yet it remains one of the most challenging diagnostic and clinical scenarios. This important reference connects between research, up-to-date clinical knowledge, and the technological tools available for diagnosis and management of thrombus in cardiovascular medicine. The book includes comprehensive descriptions and review of pathology, clinical presentations, diagnosis, pharmacotherapy, interventions and future trends. It is the perfect reference for basic science students and researchers in general and interventional cardiology, general and interventional radiology, vascular medicine specialists, and vascular, general and cardiac surgeons.\u003c\/p\u003e\n\u003cp\u003eProvides comprehensive presentation of the pathophysiology, clinical presentations and diagnosis of cardiovascular thrombosis\u003cbr\u003eIncludes the most up-to-date information on the practical management of patients with thrombus related conditions\u003cbr\u003eWritten by the leading experts in the field\u003cbr\u003eDescribes the current and upcoming pharmacotherapy and technology available for thrombus research and treatment\u003c\/p\u003e\n\u003ch2 class=\"tab-heading\"\u003eSpecification\u003c\/h2\u003e\n\u003cdiv class=\"akf-det-table\"\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003cth\u003ePublished Year\u003c\/th\u003e\n\u003ctd\u003e2018\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eLanguage\u003c\/th\u003e\n\u003ctd\u003e‎English\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003ePublisher\u003c\/th\u003e\n\u003ctd\u003eElsevier\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eEdition :\u003c\/th\u003e\n\u003ctd\u003e1\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eFormat :\u003c\/th\u003e\n\u003ctd\u003ePublisher PDF\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eFile Size :\u003c\/th\u003e\n\u003ctd\u003e27.9\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eISBN :\u003c\/th\u003e\n\u003ctd\u003e9780128126158\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e","brand":"Elsevier","offers":[{"title":"Default Title","offer_id":48080559997163,"sku":"AB9","price":39.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0821\/3105\/8923\/files\/HospitalforSpecialSurgeryContemporaryTopicsinVasculitis2024-2026-04-11T191447.429.png?v=1775930827"},{"product_id":"hypertension-a-companion-to-braunwald-s-heart-disease-4th-edition-pdf","title":"Hypertension: A Companion to Braunwald’s Heart Disease, 4th Edition (PDF)","description":"\u003cdiv id=\"bylineInfo\" class=\"a-section a-spacing-micro bylineHidden feature\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: rgb(255, 42, 0);\"\u003e\u003cstrong\u003e(PDF ONLY)\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"color: rgb(255, 42, 0);\"\u003e\u003c\/span\u003e\n\u003c\/h2\u003e\nby\u003cspan class=\"author notFaded\" data-width=\"\"\u003e\u003cb\u003e\u003cspan\u003e \u003c\/span\u003eGeorge L. Bakris\u003cspan\u003e \u003c\/span\u003e\u003c\/b\u003e\u003cspan class=\"contribution\"\u003e\u003cspan class=\"a-color-secondary\"\u003e(Author)\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\n\u003c\/div\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cdiv id=\"description\"\u003e\n\u003cp\u003ePart of the renowned Braunwald family of references, Hypertension: A Companion to Braunwald’s Heart Disease provides today’s clinicians with clear, authoritative guidance on every aspect of managing and treating patients who suffer from hypertensive disorders. An invaluable resource for cardiologists, endocrinologists, and nephrologists, this one-stop reference covers all the latest developments from basic science to clinical trials and guidelines related to the treatment of common to complex hypertension. Now fully updated from cover to cover, the 4th Edition offers unparalleled coverage of hypertension in an accessible and user-friendly manner.\u003c\/p\u003e\n\u003cp\u003eThoroughly covers new treatment guidelines related to recent research and the latest physiologic understanding for a wide range of patients with hypertension and related co-morbidities.\u003c\/p\u003e\n\u003cp\u003eIncludes new chapters on Hypertension in Women, Mineralocorticoid Receptor Antagonists, Exercise and Hypertension, and Telemedicine\/Digital Health.\u003c\/p\u003e\n\u003cp\u003eContains new or expanded content on epidemiology, pathophysiology, immunology, clinical findings, laboratory testing, invasive and non-invasive testing, risk stratification, clinical decision-making, prognosis, and management.\u003c\/p\u003e\n\u003cp\u003eProvides new chapter summaries and a new focus on clinical and actionable content using a streamlined, narrative format.\u003c\/p\u003e\n\u003cp\u003eCovers behavior management and prevention as an integral part of hypertensive and pre-hypertensive treatment plans.\u003c\/p\u003e\n\u003cp\u003eHighlights combination drug therapies and management of chronic complications of hypertension.\u003c\/p\u003e\n\u003cp\u003eOffers expert guidance from worldwide experts in cardiology, endocrinology, and nephrology, and integrates the most recent guidelines from leading organizations around the world.\u003c\/p\u003e\n\u003ch2 class=\"tab-heading\"\u003eSpecification\u003c\/h2\u003e\n\u003cdiv class=\"akf-det-table\"\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003cth\u003eLanguage\u003c\/th\u003e\n\u003ctd\u003e‎English\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003ePublisher\u003c\/th\u003e\n\u003ctd\u003eElsevier\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eEdition :\u003c\/th\u003e\n\u003ctd\u003e4\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eFormat :\u003c\/th\u003e\n\u003ctd\u003ePDF\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eFile Size :\u003c\/th\u003e\n\u003ctd\u003e80.9\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Elsevier","offers":[{"title":"Default Title","offer_id":48080627564779,"sku":"AB7","price":35.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0821\/3105\/8923\/files\/HospitalforSpecialSurgeryContemporaryTopicsinVasculitis2024-2026-04-11T193731.638.png?v=1775932116"}],"url":"https:\/\/docebook.com\/collections\/preventive-cardiology.oembed","provider":"Docebook","version":"1.0","type":"link"}